Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: Long-term follow-up of CALGB study 9712

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema, Bercedis L. Peterson, John G. Gribben, Vicki A Morrison, Kanti R. Rai, Richard A. Larson, John C. Byrd

Research output: Contribution to journal › Article › peer-review

116 Scopus citations

Fingerprint

Dive into the research topics of 'Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: Long-term follow-up of CALGB study 9712'. Together they form a unique fingerprint.

Medicine & Life Sciences